JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 14 March 2005. doi:10.1083/jcb.200411026
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 168, Number 6, 855-862
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2021K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodchild, R. E.
Right arrow Articles by Dauer, W. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodchild, R. E.
Right arrow Articles by Dauer, W. T.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Report

The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein



Rose E. Goodchild1 and William T. Dauer1,2

1 Department of Neurology, Columbia University, New York, NY 10032
2 Department of Pharmacology, Columbia University, New York, NY 10032

Correspondence to William Dauer: wtd3{at}columbia.edu


Abstract

A glutamic acid deletion ({Delta}E) in the AAA+ protein torsinA causes DYT1 dystonia. Although the majority of torsinA resides within the endoplasmic reticulum (ER), torsinA binds a substrate in the lumen of the nuclear envelope (NE), and the {Delta}E mutation enhances this interaction. Using a novel cell-based screen, we identify lamina-associated polypeptide 1 (LAP1) as a torsinA-interacting protein. LAP1 may be a torsinA substrate, as expression of the isolated lumenal domain of LAP1 inhibits the NE localization of "substrate trap" EQ-torsinA and EQ-torsinA coimmunoprecipitates with LAP1 to a greater extent than wild-type torsinA. Furthermore, we identify a novel transmembrane protein, lumenal domain like LAP1 (LULL1), which also appears to interact with torsinA. Interestingly, LULL1 resides in the main ER. Consequently, torsinA interacts directly or indirectly with a novel class of transmembrane proteins that are localized in different subdomains of the ER system, either or both of which may play a role in the pathogenesis of DYT1 dystonia.

Abbreviations used in this paper: LAP1, lamina-associated polypeptide 1; LULL1, lumenal domain like LAP1; NE, nuclear envelope; PDI, protein disulphide isomerase; ROI, region of interest; WCL, whole cell lysate; WT, wild-type.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Sticking to the nuclear envelope
Rabiya S. Tuma
J. Cell Biol. 2005 168: 848. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents